Yuyu Positive 10/160 mg
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
MFDS item code 201308545 · Approved 2013.07.30
This product's status changed to Expired on 2023.07.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood pressure control in essential hypertension through the combination of amlodipine and valsartan
Used for essential hypertension that is insufficiently controlled with monotherapy of amlodipine or valsartan.
The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). For patients with mild to moderate renal impairment (creatinine clearance above 10 mL/min), dose adjustment is not necessary. Patients with severe renal impairment (creatinine clearance below 10 mL/min) and
Safety and efficacy have not been established in pediatric patients under 18 years of age, thus its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Do not take if you have allergies to this drug's active ingredients or related medications, if you are pregnant or breastfeeding, if you have severe kidney or liver impairment, or if you have certain heart conditions. Patients with low sodium or fluid levels in the body should improve their condition before taking this medication and need to carefully monitor blood pressure and symptoms during treatment. If symptoms of hypotension occur, appropriate actions should be taken immediately. Patients with high potassium levels or those taking potassium supplements must frequently check potassium concentrations, and patients with impaired kidney function should also take caution. Patients with a history of kidney transplant or angioedema need special attention while taking this medication, and it should be discontinued immediately if angioedema symptoms appear. Patients with heart failure or post-myocardial infarction should carefully monitor kidney function and blood pressure while on this medication; acute myocardial infarction patients should be cautious when starting or increasing the dose of this medication. Dose adjustments are necessary for patients with impaired liver function, and patients with severe liver disease should avoid this medication. Dizziness or fatigue may occur while taking this medication, so caution is advised while driving or operating machinery. This medication may interact with other antihypertensives, potassium-sparing diuretics, and certain anti-inflammatory drugs; therefore, inform your healthcare provider of any other medications you are taking. Women who are pregnant or planning to become pregnant should avoid this medication, and it is not recommended for breastfeeding women. Safety and efficacy have not been adequately established for children under 18 years of age, thus its use in this population is not recommended. Elderly patients can use the same dosage as adults, but must be closely monitored for adverse reactions. Severe hypotension or cardiac issues may occur in case of an overdose, so it is important to adhere strictly to the prescribed dosage and seek medical attention if any unusual symptoms occur.
Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blistering, skin peeling, pain in oral/ocular mucosa, dyspnea or breathing difficulties, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice, pronounced overall lethargy, sudden and very severe headache, lightning headache, seizures, altered consciousness, visual disturbances, paralysis, markedly reduced urine output,
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 to 30 degrees Celsius to preserve the drug’s efficacy for a longer duration.
Bright yellow oval film-coated tablet
PTP - 28 tablets/box[(14 tablets/PTP packaging × 2)], bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.